Dong H, Yao Y, Niu Q, Gong X, et al. Comprehensive pan-cancer characterization of IRAK2 as a potential prognostic biomarker and therapeutic target with validation in hepatocellular carcinoma. BMC Cancer 2025 Dec 29. doi: 10.1186/s12885-025-15474.
PMID: 41457219